A clinical comparison published in Frontiers of Veterinary Science forms the basis for this article. The goal was to evaluate the efficacy of a nutraceutical formulation in dogs with spontaneous osteoarthritis as an alternative or complementary option to NSAIDs.
Key Findings
- Pain reduction: Both treatments significantly reduced pain scores, with comparable efficacy.
- Lameness improvement: Dogs in both groups showed improved mobility and gait quality.
- Synovial fluid quality: The nutraceutical group demonstrated superior improvements in synovial fluid characteristics, suggesting enhanced joint environment support.
- Safety profile: Unlike NSAIDs, nutraceuticals did not present the adverse effects commonly associated with long‑term pharmacological therapy.
Source: IVC Journal, August 12, 2026. Link. For practitioners, incorporating nutraceuticals into multimodal treatment regimens offers a balanced approach that prioritizes both efficacy and safety, ultimately improving the quality of life for canine patients living with osteoarthritis.
This study reinforces the role of nutraceuticals for canine osteoarthritis as effective and safe adjuncts to NSAIDs.”
Related: Adjusting OA management plans for senior dog patients in summer, Senior Dog Veterinary Society, August 7, 2026. Link. Monica Tarantino DVM, MBA, details how to adjust multimodal pain plans when heat, humidity and activity shifts affect your patients. She shares a multimodal OA management framework for senior patients.
Image: Link.
Leave a Reply